These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10867870)

  • 21. [Software and hardware for computer equipment designed for psychophysiological examination].
    Matveev EV; Gal'etov IV; Vasil'ev AA; Kravchuk AIu; Tereshkina DV
    Med Tekh; 2005; (1):4-7. PubMed ID: 15757084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Approaches to drug therapy of alcoholism].
    Burov IuV
    Vestn Akad Med Nauk SSSR; 1982; (5):72-7. PubMed ID: 7048788
    [No Abstract]   [Full Text] [Related]  

  • 23. Naltrexone in the treatment of alcohol dependence: a Canadian trial.
    Romach MK; Sellers EM; Somer GR; Landry M; Cunningham GM; Jovey RD; McKay C; Boislard J; Mercier C; Pépin JM; Perreault J; Lemire E; Baker RP; Campbell W; Ryan D
    Can J Clin Pharmacol; 2002; 9(3):130-6. PubMed ID: 12422250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol reactions after single and multiple doses of calcium cyanamide.
    Lader MH
    Q J Stud Alcohol; 1967 Sep; 28(3):468-75. PubMed ID: 6048608
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolerance to disulfiram induced by chronic alcohol intake in the rat.
    Tampier L; Quintanilla ME; Israel Y
    Alcohol Clin Exp Res; 2008 Jun; 32(6):937-41. PubMed ID: 18445101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drug treatments for alcohol problems. Response to Moncrieff & Drummond.
    Lingford-Hughes A; Marshall J
    Addiction; 1998 Jun; 93(6):925-7. PubMed ID: 9766928
    [No Abstract]   [Full Text] [Related]  

  • 28. [The similarity of the pathogenetic mechanisms of alcoholism and drug dependence and the means of searching for agents for treating these diseases].
    Anokhina IP; Kogan BM; Man'kovskaia IV; Reshchikova EV; Stanishevskaia AV
    Farmakol Toksikol; 1990; 53(4):4-9. PubMed ID: 2226760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfiram treatment increases plasma and red blood cell acetaldehyde in abstinent alcoholics.
    Rosman AS; Waraich A; Baraona E; Lieber CS
    Alcohol Clin Exp Res; 2000 Jul; 24(7):958-64. PubMed ID: 10923997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rational approach to the pharmacotherapy of alcohol dependence.
    Petrakis IL
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S3-12. PubMed ID: 17114952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of vasopressin on long-term memory (psychophysiological and clinical aspects)].
    Morozov GV; Ivanitskiĭ AM; Strelets VB; Artseulova OK; Pirogova EK
    Fiziol Zh SSSR Im I M Sechenova; 1984 Jul; 70(7):990-6. PubMed ID: 6489570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ambulatory trial of Tiapridal in chronic alcoholism].
    Cloquette R
    Brux Med; 1977 May; 57(5):227-30. PubMed ID: 880503
    [No Abstract]   [Full Text] [Related]  

  • 33. [Psychosis during and after disulfiram use].
    Verbon H; de Jong CA
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):571-3. PubMed ID: 11938582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired theta phase-resetting underlying auditory N1 suppression in chronic alcoholism.
    Fuentemilla L; Marco-Pallarés J; Gual A; Escera C; Polo MD; Grau C
    Neuroreport; 2009 Feb; 20(3):337-42. PubMed ID: 19188856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physical compatibility of 10% alcohol in 5% dextrose injection with selected drugs during simulated Y-site administration.
    Thoma LA; Johnson-Singh A; Wood GC; Wolfe JL
    Am J Health Syst Pharm; 2000 Dec; 57(24):2286-7. PubMed ID: 11146976
    [No Abstract]   [Full Text] [Related]  

  • 36. Metadoxine in the treatment of acute and chronic alcoholism: a review.
    Addolorato G; Ancona C; Capristo E; Gasbarrini G
    Int J Immunopathol Pharmacol; 2003; 16(3):207-14. PubMed ID: 14611722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative electroencephalography features and cognitive impairment in alcoholic patients].
    de Quesada-Martínez ME; Díaz-Pérez GF; Herrera-Ramos A; Tamayo-Porras M; Rubio-López R
    Rev Neurol; 2007 Jan 16-31; 44(2):81-8. PubMed ID: 17236146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological treatment options for prevention of alcohol relapse].
    Heberlein A; Bleich S; Kornhuber J; Hillemacher T
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):421-8. PubMed ID: 18604776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of glycine on EEG parameters and the sensorimotor activity in normal and alcoholic subjects].
    Mashkova VM
    Fiziol Cheloveka; 2000; 26(4):13-7. PubMed ID: 11004744
    [No Abstract]   [Full Text] [Related]  

  • 40. Sleep electroencephalographic spectral power after withdrawal from alcohol in alcohol-dependent patients.
    Feige B; Scaal S; Hornyak M; Gann H; Riemann D
    Alcohol Clin Exp Res; 2007 Jan; 31(1):19-27. PubMed ID: 17207097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.